Shigellaspp. Antimicrobial Drug Resistance, Papua New Guinea, 2000–2009

Alexander Rosewell,Glen Mola,Berry Ropa,Enoch Posanai,Anthony Zwi,C Raina Macintyre,Samir R Dutta

doi:10.3201/eid1611.101025

Abstract

<i>Shigella</i>spp. Antimicrobial Drug Resistance, Papua New Guinea, 2000–2009

Highlights

In Papua New Guinea, diarrhea is a major cause of hospital admission and death [3]; Shigella spp. are among the most common causes of enteric bacterial infection [4,5], and S. flexneri is the most common serotype [3,6]
The antimicrobial drug currently recommended for patients with bloody diarrhea in primary healthcare settings in Papua New Guinea is co-trimoxazole [8]; ciprofloxacin is available only in hospitals
In August 2009, an epidemic of multidrug-resistant S. flexneri infection associated with widespread illness and death across 4 provinces of Papua New Guinea was reported to health authorities

Summary

Introduction

Nocht Institute for Tropical Medicine, Hamburg, Germany Antimicrobial Drug Resistance, Papua New Guinea, 2000– In Papua New Guinea, diarrhea is a major cause of hospital admission and death [3]; Shigella spp. are among the most common causes of enteric bacterial infection [4,5], and S. flexneri is the most common serotype [3,6]. Multidrug resistance of shigellae is not new [1]; many countries have

Results

Conclusion